Abstract:Exosomal biomarker detection holds great importance in the field of in vitro diagnostics, offering a non-invasive and highly sensitive approach for early disease detection and personalized treatment. Here, we proposed an "APPROACH" strategy, combining aptamer-mediated proximity ligation assay (PLA) with rolling circle amplification (RCA) and time-resolved Förster resonance energy transfer (TR-FRET) for the sensitive and semi-homogenous detection of exosomal biomarkers. PLA probes consisted of a cholesterol-conjugated oligonucleotide, which anchored to the membrane of an exosome, and a specific aptamer oligonucleotide that recognized a target protein of the exosome; the proximal binding of pairs of PLA probes to the same exosome positioned the oligonucleotides in the vicinity of each other, guiding the hybridization and ligation of two subsequently added backbone and connector oligonucleotides to form a circular DNA molecule. Circular DNA formed from PLA underwent rolling circle amplification (RCA) for signal amplification, and the resulting RCA products were subsequently quantified by TR-FRET. The limits of detection provided by APPROACH for the exosomal biomarkers CD63, PD-L1, and HER2 were 0.46 ng∙μL−1, 0.77 ng∙μL−1, and 1.1 ng∙μL−1, respectively, demonstrating excellent analytical performance with high sensitivity and quantification accuracy. Furthermore, the strategy afforded sensitive detection of exosomal CD63 with a LOD of 1.56 ng∙μL−1 in complex biological matrices, which underscored its anti-interference capability and potential for in vitro detection. The proposed strategy demonstrates wide-ranging applicability in quantifying diverse exosomal biomarkers while exhibiting robust analytical characteristics, including high sensitivity and accuracy.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop a highly sensitive, semi - homogeneous exosome biomarker detection method. Specifically, the authors proposed a strategy named "APPROACH", which combines aptamer - mediated proximity ligation assay (PLA), rolling - circle amplification (RCA) and time - resolved fluorescence resonance energy transfer (TR - FRET) for sensitive and semi - homogeneous detection of exosome biomarkers. The main goal of the paper is to improve the sensitivity and accuracy of exosome biomarker detection, while reducing interference in complex biological matrices, in order to achieve more effective early - disease diagnosis and personalized treatment. ### Research Background Exosomes are nanoscale extracellular vesicles released by cells under physiological and pathological conditions. They promote inter - cellular communication by transporting various molecular cargos, which can regulate the functions of receptor cells and participate in disease progression. Since exosomes are encapsulated by a lipid bilayer, are stable, and can be detected through easily accessible body fluids, detecting biomarkers in exosomes has great potential for disease diagnosis and treatment evaluation. Tumor - derived exosomes carry common vesicle transmembrane proteins (such as CD9, CD63 and CD81) as well as cancer - related membrane proteins (such as EpCAM, EGFR and PD - L1). ### Limitations of Existing Technologies Currently, researchers have developed a variety of techniques based on fluorescence, electrochemical detection, Raman spectroscopy and mass spectrometry to detect exosome biomarkers. Although these techniques can achieve high - sensitivity and - specificity quantification, they also have certain limitations: - **Electrochemical methods**: Although simple, low - cost and fast - detecting, they are easily interfered by other electroactive substances in complex biological matrices, affecting the test precision. - **Raman spectroscopy and mass spectrometry**: They provide valuable molecular composition information and have high specificity, but usually require professional knowledge and time - consuming sample preparation, which limits their wide application in point - of - care testing and personalized treatment. ### Research Methods To solve the above problems, the authors proposed the "APPROACH" strategy. The main steps of this strategy include: 1. **Exosome enrichment**: Use aldehyde/sulfate latex microspheres to enrich exosomes and remove unbound PLA probes by centrifugation. 2. **PLA reaction**: Specific aptamers recognize target proteins on the exosome surface, and cholesterol - modified primers are inserted into the lipid membrane to form a circular DNA template. 3. **RCA reaction**: Using the circular DNA as a template, perform rolling - circle amplification to generate a large number of signal - amplified products. 4. **TR - FRET detection**: Use CoraFluor - like - NHS (Tb) and Cy5 to label RCA products, and perform direct fluorescence quantification through time - resolved fluorescence resonance energy transfer to avoid background interference. ### Experimental Results The experimental results show that the APPROACH strategy has detection limits of 0.46 ng·µL⁻¹, 0.77 ng·µL⁻¹ and 1.1 ng·µL⁻¹ for exosome biomarkers CD63, PD - L1 and HER2 respectively, showing excellent analytical performance and high sensitivity. In addition, the strategy has a detection limit of 1.56 ng·µL⁻¹ in the complex biological matrix of exosome CD63, demonstrating its anti - interference ability and potential in vitro detection application value. ### Conclusion In summary, this paper proposes a "APPROACH" strategy that combines aptamer - mediated PLA, RCA and TR - FRET, achieving highly sensitive, semi - homogeneous detection of exosome biomarkers. This method shows good anti - interference ability in complex biological matrices and has broad application prospects, especially in early - disease diagnosis and personalized treatment.

APPROACH: Sensitive Detection of Exosomal Biomarkers by Aptamer-Mediated Proximity Ligation Assay and Time-Resolved Förster Resonance Energy Transfer

Simultaneous Detection of Exosomal Membrane Protein and RNA by Highly Sensitive Aptamer Assisted Multiplex-PCR.

Dual-Recognition Triggered Proximity Ligation Combined with a Rolling Circle Amplification Strategy for Analysis of Exosomal Protein-Specific Glycosylation.

A PLA-mediated transistor biosensor enables specific identification of tumor-derived exosomal PD-L1

Proximity ligation hybridization triggered structure-switching based signal amplification strategy for sensitive and accurate exosomes detection

Accurate Cancer Diagnosis and Stage Monitoring Enabled by Comprehensive Profiling of Different Types of Exosomal Biomarkers: Surface Proteins and Mirnas

An easy-operation aptasensor for simultaneous detection of multiple tumor-associated exosomal proteins based on multicolor fluorescent DNA nanoassemblies

Dual signal Amplification-Mediated Aptamer-Based electrochemical biosensor for sensitive detection of exosomes

Digital-resolution and Highly Sensitive Detection of Multiple Exosomal Small RNAs by DNA Toehold Probe-Based Photonic Resonator Absorption Microscopy

Aptamer-bivalent-cholesterol-mediated proximity entropy-driven exosomal protein reporter for tumor diagnosis

Selective detection of exosomes by elemental labeling ICP-MS based on cholesterol-EpCAM aptamer proximity ligation mediated MNAzyme assembly

Molecular beacon-peptide probe based double recycling amplification for multiplexed detection of serum exosomal microRNAs

CRISPR/Cas12a and aptamer-chemiluminescence based analysis for the relative abundance determination of tumor-related protein positive exosomes for breast cancer diagnosis

Colorimetric aptasensor based on spherical nucleic acid-induced hybridization chain reaction for sensitive detection of exosomes

Integrated Dual-Biomarker Detection: Transforming Proteins and Nucleic Acids into Ssdna for Enhanced Disease Diagnosis

Nanozyme Sensor Array Plus Solvent-Mediated Signal Amplification Strategy For Ultrasensitive Ratiometric Fluorescence Detection Of Exosomal Proteins And Cancer Identification

Rolling Circle Amplification-Assisted Flow Cytometry Approach for Simultaneous Profiling of Exosomal Surface Proteins

Fabrication of an Aptamer-Coated Liposome Complex for the Detection and Profiling of Exosomes Based on Terminal Deoxynucleotidyl Transferase-Mediated Signal Amplification

Visual and Fluorescence Dual Mode Platform for Sensitive and Accurate Screening of Breast Carcinoma

Precise Capture and Direct Quantification of Tumor Exosomes via a Highly Efficient Dual-Aptamer Recognition-Assisted Ratiometric Immobilization-Free Electrochemical Strategy.

Fabrication of Aptamer-Coated Liposome Complex for the Detection and Profiling of Exosomes Based on TdT-Mediated Signal Amplification.